Abstract
In this multi center study, genetic counseling for hereditary cancer was evaluated by assessing patients’ worry, perceived risk of developing cancer and satisfaction with genetic counseling. An overall aim was to identify characteristics of vulnerable patients in order to customize genetic counseling. In addition, agreement between patients’ and counselors’ scores was measured. A total of 275 Norwegian patients were consecutively recruited, and 213 completed questionnaires before and after genetic counseling. Patients’ perceived risk decreased after the genetic counseling session. There was incongruence between risk perception expressed as a percentage and in words. Patients were significantly less worried after counseling. Higher levels of worry were predicted by low instrumental satisfaction with counseling, high degree of perceived risk of developing cancer and younger age. In conclusion, counselors met the patients’ psychological needs to a satisfactory degree during counseling. However, patients did not fully understand their risk of developing cancer.
Similar content being viewed by others
REFERENCES
Act. (2003-12-05). Act regarding human medical use of biotechnology. Norwegian legislation.
Brain, K., Norman, P., Gray, J., Rogers, C., Mansel, R., & Harper, P. (2002). A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk. Br J Cancer, 86(2), 233–238.
Braithwaite, D., Emery, J., Walter, F., Prevost, A. T., & Sutton, S. (2004). Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst, 96(2), 122–133.
Bresser, P. J., Seynaeve, C., Van Gool, A. R., Brekelmans, C. T., Meijers-Heijboer, H., van Geel, A. N., et al. (2006). Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg, 117(6), 1675–1682; discussion 1683–1674.
Brun, W., Wright, G., & Ayton, P. (1994). Risk Perception:Main Issues, Approaches and Findings in Subjective Probability (pp. 295–320). Chichester: John Wiley & Sons.
Charles, S., Kessler, L., Stopfer, J. E., Domchek, S., & Halbert, C. H. (2006). Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Educ Couns.
Claus, E. B., Risch, N. J., & Thompson, W. D. (1990). Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol, 131(6), 961–972.
Collins, V., Halliday, J., Warren, R., & Williamson, R. (2000). Cancer worries, risk perceptions and associations with interest in DNA testing and clinic satisfaction in a familial colorectal cancer clinic. Clin Genet, 58(6), 460–468.
Cull, A., Anderson, E. D., Campbell, S., Mackay, J., Smyth, E., & Steel, M. (1999). The impact of genetic counselling about breast cancer risk on women+s risk perceptions and levels of distress. Br J Cancer, 79(3–4), 501–508.
Ervin, N. E. (2006). Does patient satisfaction contribute to nursing care quality? J Nurs Adm, 36(3), 126–130.
Evans, D. G., Blair, V., Greenhalgh, R., Hopwood, P., & Howell, A. (1994). The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer, 70(5), 934–938.
Fayers, M., & Machin, D. (2000). Quality of Life. Assessment, Analysis and Interpretation. West Sussex, England: Wiley.
Garber, J. E., & Offit, K. (2005). Hereditary cancer predisposition syndromes. J Clin Oncol, 23(2), 276–292.
Gold, D. T., & McClung, B. (2006). Approaches to patient education: emphasizing the long-term value of compliance and persistence. Am J Med, 119(4 Suppl 1), S32–37.
Holloway, S., Porteous, M., Cetnarskyj, R., Anderson, E., Rush, R., Fry, A. et al. (2004). Patient satisfaction with two different models of cancer genetic services in south-east Scotland. Br J Cancer, 90(3), 582–589.
Hopwood, P. Wonderling, D., Watson, M., Cull, A., Douglas, F., Cole, T., et al. (2004). A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes. Br J Cancer, 91(5), 884–892.
Hunfeld, J. A., Leurs, A., De Jong, M., Oberstein, M. L., Tibben, A., Wladimiroff, J. W, et al. (1999). Prenatal consultation after a fetal anomaly scan: Videotaped exploration of physician+s attitude and patient+s satisfaction. Prenat Diagn, 19(11), 1043–1047.
Kinney, A. Y., Choi, Y. A., DeVellis, B., Kobetz, E., Millikan, R. C., & Sandler, R. S. (2000). Interest in genetic testing among first-degree relatives of colorectal cancer patients. Am J Prev Med, 18(3), 249–252.
Lampic, C., & Sjoden, P. O. (2000). Patient and staff perceptions of cancer patients+ psychological concerns and needs. Acta Oncol, 39(1), 9–22.
Lerman, C., Lustbader, E., Rimer, B., Daly, M., Miller, S., Sands, C., et al. (1995). Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst, 87(4), 286–292.
Liden, A., Berglund, G., Hansson, M. G., Rosenquist, R., Sjoden, P. O., & Nordin, K. (2003). Genetic counselling for cancer and risk perception. Acta Oncol, 42(7), 726–734.
Michie, S., McDonald, V., & Marteau, T. M. (1997). Genetic counselling: Information given, recall and satisfaction. Patient Educ Couns, 32(1–2), 101–106.
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266(5182), 66–71.
Moller, P., Borg, A., Evans, D. G., Haites, N., Reis, M. M., Vasen, H, et al. (2002). Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy. Int J Cancer, 101(6), 555–559.
Moller, P., Evans, G., Haites, N., Vasen, H., Reis, M. M., Anderson, E. et al. (1999). Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer. Dis Markers, 15(1–3), 207–211.
Moller, P., Reis, M. M., Evans, G., Vasen, H., Haites, N., Anderson, E. et al. (1999). Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group. Dis Markers, 15(1–3), 179–186.
Mulvihill, J. J., & Stadler, M. P. (1996). Breast cancer risk analysis and counseling. Clin Obstet Gynecol, 39(4), 851–859.
NBCG, N. B. C. G. (2003). Brystkreft -- Diagnostikk og Behandling. Oslo:The Norwegian Cancer Society.
Nordin, K., Liden, A., Hansson, M., Rosenquist, R., & Berglund, G. (2002). Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer. J Med Genet, 39(9), 689–694.
Ollikainen, M., Abdel-Rahman, W. M., Moisio, A. L., Lindroos, A., Kariola, R., Jarvela, I, et al. (2005). Molecular analysis of familial endometrial carcinoma: A manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome? J Clin Oncol, 23(21), 4609–4616.
Pasacreta, J. V. (2003). Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Cancer Invest, 21(4), 588–623.
Pearn, J. H. (1973). Patients+ subjective interpretation of risks offered in genetic counselling. J Med Genet, 10(2), 129–134.
Pullman, D., & Hodgkinson, K. (2006). Genetic knowledge and moral responsibility: ambiguity at the interface of genetic research and clinical practice. Clin Genet, 69(3), 199–203.
Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Estabrooks Hahn, S., Strecker, M. N., et al. (2006). A new definition of genetic counseling: national society of genetic counselors+ task force report. J Genet Couns, 15(2), 77–83. DOI: 10.1007/s10897-005-9014-3
Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R., Henson, D. E., Jass, J. R., Khan, P. M., et al. (1997). A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst, 89(23), 1758–1762.
Shiloh, S., Avdor, O., & Goodman, R. M. (1990). Satisfaction with genetic counseling: dimensions and measurement. Am J Med Genet, 37(4), 522–529.
Slovic, P. (2000). The perception of risk. London: Earthscan Publications Ltd.
SPSS13.0. (2004). Users manual. Chicago.
StatXact. (2004). Users manual, Cytel Statistica Software.
Stormorken, A. T., Bowitz-Lothe, I. M., Noren, T., Kure, E., Aase, S., Wijnen, J., et al. (2005). Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer. J Clin Oncol, 23(21), 4705–4712.
Tercyak, K. P., Demarco, T. A., Mars, B. D., & Peshkin, B. N. (2004). Women+s satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects. Am J Med Genet A, 131(1), 36–41.
Trepanier, A., Ahrens, M., McKinnon, W., Peters, J., Stopfer, J., Grumet, S. C., et al. (2004). Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns, 13(2), 83–114.
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Ruschoff, J., et al. (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst, 96(4), 261–268.
van Dooren, S., Rijnsburger, A. J., Seynaeve, C., Duivenvoorden, H. J., Essink-Bot, M. L., Tilanus-Linthorst, M. M., et al. (2004). Psychological distress in women at increased risk for breast cancer: the role of risk perception. Eur J Cancer, 40(14), 2056–2063.
Vasen, H. F., Watson, P., Mecklin, J. P., & Lynch, H. T. (1999). New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology, 116(6), 1453–1456.
Vernon, S. W. (1997). Participation in colorectal cancer screening: a review. J Natl Cancer Inst, 89(19), 1406–1422.
Vernon, S. W., Gritz, E. R., Peterson, S. K., Amos, C. I., Perz, C. A., Baile, W. F., et al. (1997). Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol, 16(1), 73–86.
Wagner, A., van Kessel, I., Kriege, M. G., Tops, C. M., Wijnen, J. T., Vasen, H. F., et al. (2005). Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer, 4(4), 295–300.
Watson, M., Kash, K. M., Homewood, J., Ebbs, S., Murday, V., & Eeles, R. (2005). Does genetic counseling have any impact on management of breast cancer risk? Genet Test, 9(2), 167–174.
Watson, M., Lloyd, S., Davidson, J., Meyer, L., Eeles, R., Ebbs, S., et al. (1999). The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer, 79(5–6), 868–874.
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., et al. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature, 378(6559), 789–792.
ACKNOWLEDGEMENTS
The authors thank all patients and counselors who participated in the study. The authors are grateful for the assistance with data collection provided by the Center of Medical Genetics and Molecular Medicine, Haukeland University Hospital, Norway and the Center of Medical Genetics, St. Olav Hospital, Norway. We also thank our funding sources: The Norwegian Research Board (Functional Genome project (FUGE) no 155757/510).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bjorvatn, C., Eide, G., Hanestad, B. et al. Risk Perception, Worry and Satisfaction Related to Genetic Counseling for Hereditary Cancer. J Genet Counsel 16, 211–222 (2007). https://doi.org/10.1007/s10897-006-9061-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-006-9061-4